Searched for
PHARMA IPO INDIA
We expect interest rates to be left the way they are: Ficci chief Anant GoenkaFicci president Anant Goenka advocates for steady interest rates, citing supply-side price pressures from the West Asia crisis. He suggests...04 Jun, 2026, 12.26 AM IST- Ahead of Market: 10 things that will decide stock market action on WednesdayDomestic equity benchmarks ended lower on Tuesday, snapping a three-session rally amid profit booking in financial, realty and consumer sto...26 May, 2026, 10.20 PM IST
- IPO investors brace for 73 lock-in expiries worth $34 billion in three months. Will your portfolio be impacted?India’s stock market is set for a wave of IPO lock-in expiries over the next three months, with shares worth $34 billion from 73 recently l...20 May, 2026, 10.03 AM IST
- More companies may take confidential route to file IPO papersMore companies are choosing to file their initial public offering documents confidentially. This move is driven by uncertainty surrounding ...20 May, 2026, 05.35 AM IST
- “Reallocate, Diversify, Reposition”: Ajay Srivastava flags rising macro risks for investorsIndian markets face rising macro risks from global shocks, currency pressure, and energy prices, impacting domestic consumption and corpora...15 May, 2026, 01.03 PM IST
- MSMEs key to creating 20 lakh jobs in Andhra: Minister Nara LokeshThe government is promoting decentralized development through clusters and simplifying business processes. Plans are underway to list 100 A...14 May, 2026, 01.39 PM IST
- IPO Calendar: 2 issues to keep investors busy but mainboard activity remains mutedIndia's primary market is set for a busy week with two SME IPOs. RFBL Flexi Pack and Goldline Pharmaceutical will open for subscription on ...09 May, 2026, 10.15 AM IST
- IPO investors brace for 83 lock-in expiries worth $55 billion in three months. Do you own any?IPO investors are bracing for a significant wave of lock-in expiries between May and August, with shares of 83 newly-listed companies value...05 May, 2026, 09.56 AM IST
- Rupee at 95, crude at $120+: Why India's markets are flying blind into a stormMarket expert Sudip Bandyopadhyay warns Indian markets face significant risks. High oil prices and a potential monsoon deficit are major co...01 May, 2026, 09.49 AM IST
- Are metals turning defensive? 5-year returns rival, even beat traditional safe havensMetal stocks are outperforming defensive sectors, delivering strong returns driven by structural demand shifts and supply constraints. Fact...28 Apr, 2026, 10.34 AM IST
- Bain Capital sole contender for Vitabiotics buyBain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...21 Apr, 2026, 08.37 AM IST
- India's 30-year economic model is over; time to pivot from IT to manufacturing: Saurabh MukherjeaSaurabh Mukherjea believes India's long-standing economic model is concluding. He anticipates rising inflation and a weakening rupee impact...15 Apr, 2026, 02.27 PM IST
- D-Street week ahead: Q4 earnings, Iran-US talks outcome to drive markets in truncated trading weekNifty posted its best weekly gain since February 2021, rising 6% on easing geopolitical tensions and falling volatility. Analysts see conti...12 Apr, 2026, 04.38 PM IST
- Speciality Medicines IPO: SME stock to list today. Check price band, other detailsSpeciality Medicines shares debut on the BSE SME platform today. The company's IPO, a fresh issue, sought to raise approximately Rs 29 cror...30 Mar, 2026, 07.24 AM IST
- Sai Parenteral IPO Day 3: 43% subscribed; here’s a look at GMP and key details; Should you invest?Sai Parenteral IPO saw 43% subscription on Day 3, with strong NII interest but weak retail participation. Despite no GMP indicating a flat ...27 Mar, 2026, 11.27 AM IST
- Sai Parenteral’s IPO: Issue subscribed just 4% on day 1. Check price band, GMPSai Parenteral’s IPO opened with weak demand, subscribing just 4% on day one amid no grey market premium. While retail and NII interest rem...24 Mar, 2026, 07.06 PM IST
- Gland Pharma IPO to open on Nov 9; price band fixed at Rs 1,490-1,500 per shareThe Gland Pharma IPO, India’s largest IPO in the pharmaceutical sector, comprises a fresh issue aggregating up to Rs 1,250 crore and an off...04 Nov, 2020, 12.23 PM IST
Load More
